145 related articles for article (PubMed ID: 23090498)
1. Interferon-stimulated gene 15 as a general marker for acute and chronic neuronal injuries.
Wang RG; Kaul M; Zhang DX
Sheng Li Xue Bao; 2012 Oct; 64(5):577-83. PubMed ID: 23090498
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
3. Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.
Wang R; Yang B; Zhang D
Glia; 2011 Jun; 59(6):946-58. PubMed ID: 21446050
[TBL] [Abstract][Full Text] [Related]
4. Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
Lee JC; Shin JH; Park BW; Kim GS; Kim JC; Kang KS; Cha CI
Brain Res; 2012 Jan; 1433():20-8. PubMed ID: 22137654
[TBL] [Abstract][Full Text] [Related]
5. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.
Korhonen P; Pollari E; Kanninen KM; Savchenko E; Lehtonen Š; Wojciechowski S; Pomeshchik Y; Van Den Bosch L; Goldsteins G; Koistinaho J; Malm T
IBRO Rep; 2019 Jun; 6():74-86. PubMed ID: 30705990
[TBL] [Abstract][Full Text] [Related]
6. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?
D'Arrigo A; Colavito D; Peña-Altamira E; Fabris M; Dam M; Contestabile A; Leon A
J Mol Neurosci; 2010 Jul; 41(3):404-15. PubMed ID: 20177826
[TBL] [Abstract][Full Text] [Related]
8. Region-specific changes in the immunoreactivity of TRPV4 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
Lee JC; Joo KM; Choe SY; Cha CI
J Mol Histol; 2012 Dec; 43(6):625-31. PubMed ID: 22714109
[TBL] [Abstract][Full Text] [Related]
9. The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression.
Jokic N; Yip PK; Michael-Titus A; Priestley JV; Malaspina A
BMC Genomics; 2010 Nov; 11():633. PubMed ID: 21078175
[TBL] [Abstract][Full Text] [Related]
10. Assessment of metal concentrations in the SOD1
Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study on the distribution of glycogen synthase kinase 3alpha in the central nervous system of SOD1(G93A) transgenic mice.
Chung YH; Joo KM; Kim DJ; Kim SS; Kim KY; Lee WB; Cha CI
Neurol Res; 2008 Nov; 30(9):926-31. PubMed ID: 18671898
[TBL] [Abstract][Full Text] [Related]
12. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)
Silverman JM; Christy D; Shyu CC; Moon KM; Fernando S; Gidden Z; Cowan CM; Ban Y; Stacey RG; Grad LI; McAlary L; Mackenzie IR; Foster LJ; Cashman NR
J Biol Chem; 2019 Mar; 294(10):3744-3759. PubMed ID: 30635404
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
14. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
Uccelli A; Milanese M; Principato MC; Morando S; Bonifacino T; Vergani L; Giunti D; Voci A; Carminati E; Giribaldi F; Caponnetto C; Bonanno G
Mol Med; 2012 Jul; 18(1):794-804. PubMed ID: 22481270
[TBL] [Abstract][Full Text] [Related]
15. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
16. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.
Liang X; Wang Q; Shi J; Lokteva L; Breyer RM; Montine TJ; Andreasson K
Ann Neurol; 2008 Sep; 64(3):304-14. PubMed ID: 18825663
[TBL] [Abstract][Full Text] [Related]
17. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
Kadoyama K; Funakoshi H; Ohya-Shimada W; Nakamura T; Matsumoto K; Matsuyama S; Nakamura T
Neurosci Res; 2009 Oct; 65(2):194-200. PubMed ID: 19595710
[TBL] [Abstract][Full Text] [Related]
18. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
19. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
Deitch JS; Alexander GM; Del Valle L; Heiman-Patterson TD
J Neurol Sci; 2002 Jan; 193(2):117-26. PubMed ID: 11790392
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus.
Stieber A; Gonatas JO; Gonatas NK
J Neurol Sci; 2000 Feb; 173(1):53-62. PubMed ID: 10675580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
